Vir Biotechnology, Inc. ($VIR)
Filing Information
| Accession Number | 0001628280-26-011330 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 25, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
167,089
Total Value
$15,568.90
P&L
+inf% (+$1,522,884.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Financial Officer | Common Stock | โ | Feb 22, 2026 | Grant/Award | 55,000 | $0.00 | $0.00 | 166,338 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Common Stock | โ | Feb 23, 2026 | Sale | 2,089 | $7.45 | $15,568.90 | 164,249 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Feb 22, 2026 | Grant/Award | 110,000 | $0.00 | $0.00 | 110,000 | Direct | โ | View Details |